Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-04-06 9:59 pm Sale | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | FORMAN ERIC | 110,431 0.075% | -1,306,152 (-92.20%) | View |
| 2022-04-06 9:58 pm Purchase | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | KRINSKY GLENN | 1,474,998 10.73% | 1,474,998 (New Position) | View |
| 2022-01-03 7:32 pm Sale | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | SABBY MANAGEMENT LLC | 0 0% | -1,081,081 (Position Closed) | View |
| 2021-03-03 07:45 am Purchase | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | SABBY MANAGEMENT LLC | 1,081,081 11% | 1,081,081 (New Position) | View |
| 2020-12-16 7:57 pm Purchase | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | Ho Hung Tak | 1,084,210 8.73% | 1,084,210 (New Position) | View |
| 2020-12-16 7:54 pm Purchase | 13D | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | Kovach John S | 1,561,283 12.6% | 1,561,283 (New Position) | View |
| 2020-12-16 7:52 pm Purchase | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | Schwartzberg Gil | 2,144,985 16.2% | 2,144,985 (New Position) | View |
| 2020-12-16 6:46 pm Purchase | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | GREENBERG ROBERT | 1,380,264 11.15% | 1,380,264 (New Position) | View |
| 2020-12-16 6:38 pm Purchase | 13G | LIXTE BIOTECHNOLOGY HLDGS INC LIXT | FORMAN ERIC | 1,416,583 11.38% | 1,416,583 (New Position) | View |